blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.
  1. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  2. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Blepharitis - limited revision. AAO. www.aao.org/ppp. 2011.
  3. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern® Guidelines. Blepharitis. AAO. http://www.aao.org/preferred-practice-pattern/blepharitis-ppp.
  4. American Optometric Association Original Consensus Panel. Optometric clinical practice guideline. Care of the patient with ocular surface disorders. American Optometric Association. St. Louis, MO; 2011.
  5. Fort G, Mikolich D. Blepharitis. Ferri: Ferri’s clinical advisor. 1st: Mosby, an imprint of Elsevier; 2012.
  6. Ganatra J, Goldstein M. Blepharitis. In: Yanoff M, Duker JS, et al. Ophthalmology. 3rd ed: Mosby, an imprint of Elsevier; 2009.
  7. Shtein RM. Blepharitis. UpToDate. http://uptodate.com. 2015 Mar.
Editor's Recommendations
Most Read Articles
Tristan Manalac, 25 Jan 2020
Unusual involvement of the eyes with atypical presentations may occur in patients with inflammatory bowel diseases (IBD) on antitumour necrosis factor (anti-TNF) therapy, according to a recent study presented at the 2019 Advances in Inflammatory Bowel Diseases Annual Meeting (AIBD 2019).